{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:41:33Z","timestamp":1780404093243,"version":"3.54.1"},"reference-count":199,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Over the last century, there has been a gradual but sustained increase in life expectancy\nglobally. A consequence of increased life expectancy is an associated rise in the prevalence of agerelated\nchronic debilitating neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's\ndisease, Huntington's disease, and multiple sclerosis. These disorders, which are generally\ncharacterised by the loss of motor\/sensory neurons and cognitive decline, have continued to confound\nresearchers who are working tirelessly to define their pathogenetic mechanisms and develop\neffective therapies. In the last few years, there has been increasing evidence of the existence of a\nrelationship between energy metabolism and neurodegeneration, with reports that type 2 diabetes\nmellitus increases the risk of AD. Evidence from preclinical and epidemiologic studies has associated\ndysmetabolism and dysmetabolic syndromes with the development of neurodegenerative changes.\nMore recently, diabetes mellitus and energy dysmetabolism have been linked to the aetiopathogenesis\nof AD. Moreover, metabolic hormones, including ghrelin, leptin, insulin, and insulin-like\ngrowth factor (IGF)-1, have been reported to play key roles in the regulation of neuronal injury and\nloss in neurodegenerative diseases like AD. In this narrative review, we examine the current scientific\nevidence regarding the role of dysmetabolism (including diabetes mellitus and metabolic syndrome)\nin AD and how it impacts disease progression and the development of novel therapies in\nAD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399819666230102141154","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T05:43:09Z","timestamp":1672724589000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diabetes Mellitus and Energy Dysmetabolism in Alzheimer\u2019s Disease:\nUnderstanding the Relationships and Potential Therapeutic Targets"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-7050","authenticated-orcid":true,"given":"Adejoke Y.","family":"Onaolapo","sequence":"first","affiliation":[{"name":"Department of Anatomy, Behavioural Neuroscience Unit, Neurobiology Subdivision, Ladoke Akintola University of\nTechnology, Ogbomoso, Oyo State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-9740","authenticated-orcid":true,"given":"Folusho O.","family":"Ojo","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Ladoke Akintola University of Technology, Ogbomoso,\nOyo State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunto O.","family":"Adeleye","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Falade","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2142-6046","authenticated-orcid":true,"given":"Olakunle J.","family":"Onaolapo","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Behavioural Neuroscience Unit, Neurobiology Subdivision, Ladoke Akintola University of\nTechnology, Ogbomoso, Oyo State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2021","unstructured":"Global Health Estimate: Life expectancy and the leading causes of death and mortality. In: Global health Observatory2021"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Hou Y.","year":"2019","unstructured":"Hou Y.; Dan X.; Babbar M.; Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 2019,15(10),565-581","journal-title":"Nat Rev Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"Dugger B.N.","year":"2017","unstructured":"Dugger B.N.; Dickson D.W.; Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 2017,9(7),a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","volume":"65","author":"Procaccini C.","year":"2016","unstructured":"Procaccini C.; Santopaolo M.; Faicchia D.; Role of metabolism in neurodegenerative disorders. Metabolism 2016,65(9),1376-1390","journal-title":"Metabolism"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Chen Z.","year":"2013","unstructured":"Chen Z.; Zhong C.; Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies. Prog Neurobiol 2013,108,21-43","journal-title":"Prog Neurobiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11011-014-9631-3","volume":"30","author":"Cai Z.","year":"2015","unstructured":"Cai Z.; Xiao M.; Chang L.; Yan L.J.; Role of insulin resistance in Alzheimer\u2019s disease. Metab Brain Dis 2015,30(4),839-851","journal-title":"Metab Brain Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jnr.23777","volume":"95","author":"Daulatzai M.A.","year":"2017","unstructured":"Daulatzai M.A.; Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer\u2019s disease. J Neurosci Res 2017,95(4),943-972","journal-title":"J Neurosci Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"560375","DOI":"10.3389\/fendo.2020.560375","volume":"11","author":"Berlanga-Acosta J.","year":"2020","unstructured":"Berlanga-Acosta J.; Guill\u00e9n-Nieto G.; Rodr\u00edguez-Rodr\u00edguez N.; Insulin resistance at the crossroad of Alzheimer disease pathology: A review. Front Endocrinol 2020,11,560375","journal-title":"Front Endocrinol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/metabo10110450","volume":"10","author":"B\u0142aszczyk JW","year":"2020","unstructured":"B\u0142aszczyk JW; Energy metabolism decline in the aging brain-pathogenesis of neurodegenerative disorders. Metabolites 2020,10(11),450","journal-title":"Metabolites"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.3390\/ijms22189987","volume":"22","author":"S\u0119dzikowska A","year":"2021","unstructured":"S\u0119dzikowska A; Szablewski L.; Insulin and insulin resistance in Alzheimer\u2019s disease. Int J Mol Sci 2021,22(18),9987","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5350\/Sleep.Hypn.2019.21.0175","volume":"21","author":"Onaolapo O.J.","year":"2018","unstructured":"Onaolapo O.J.; Onaolapo A.Y.; Melatonin and major neurocognitive disorders: Beyond the management of sleep and circadian rhythm dysfunction. Sleep Hypn 2018,21(1),73-96","journal-title":"Sleep Hypn"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.3390\/ijms21165858","volume":"21","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Kabir M.T.; Rahman M.S.; Revisiting the amyloid cascade hypothesis: from anti-a\u03b2 therapeutics to auspicious new ways for Alzheimer\u2019s disease. Int J Mol Sci 2020,21(16),5858","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.bp.115.167569","volume":"208","author":"Harrison J.R.","year":"2016","unstructured":"Harrison J.R.; Owen M.J.; Alzheimer\u2019s disease: The amyloid hypothesis on trial. Br J Psychiatry 2016,208(1),1-3","journal-title":"Br J Psychiatry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/d41586-018-05719-4","volume":"559","author":"Makin S.","year":"2018","unstructured":"Makin S.; The amyloid hypothesis on trial. Nature 2018,559(7715),S4-S7","journal-title":"Nature"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"Panza F.","year":"2019","unstructured":"Panza F.; Lozupone M.; Logroscino G.; Imbimbo B.P.; A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease. Nat Rev Neurol 2019,15(2),73-88","journal-title":"Nat Rev Neurol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"813208","DOI":"10.3389\/fcvm.2022.813208","volume":"9","author":"Chen K.","year":"2022","unstructured":"Chen K.; Zhuang Z.; Shao C.; Roles of cardiometabolic factors in mediating the causal effect of type 2 diabetes on cardiovascular diseases: a two-step, two-sample multivariable mendelian randomization study. Front Cardiovasc Med 2022,9,813208","journal-title":"Front Cardiovasc Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"832707","DOI":"10.3389\/fphar.2022.832707","volume":"13","author":"Hu Y.","year":"2022","unstructured":"Hu Y.; Zhou Y.; Yang Y.; Metformin protects against diabetes-induced cognitive dysfunction by inhibiting mitochondrial fission protein DRP1. Front Pharmacol 2022,13,832707","journal-title":"Front Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.sjbs.2019.12.028","volume":"27","author":"Jayaraj R.L.","year":"2020","unstructured":"Jayaraj R.L.; Azimullah S.; Beiram R.; Diabetes as a risk factor for Alzheimer\u2019s disease in the Middle East and its shared pathological mediators. Saudi J Biol Sci 2020,27(2),736-750","journal-title":"Saudi J Biol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.3390\/ijms22115526","volume":"22","author":"Kubis-Kubiak A.","year":"2021","unstructured":"Kubis-Kubiak A.; Wiatrak B.; Piwowar A.; The impact of high glucose or insulin exposure on S100B protein levels, oxidative and nitrosative stress and DNA damage in neuron-like cells. Int J Mol Sci 2021,22(11),5526","journal-title":"Int J Mol Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4981814","volume":"2020","author":"Sun Y.","year":"2020","unstructured":"Sun Y.; Ma C.; Sun H.; Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease. J Diabetes Res 2020,2020,1-12","journal-title":"J Diabetes Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fnins.2019.00556","volume":"13","author":"Gamba P.","year":"2019","unstructured":"Gamba P.; Staurenghi E.; Testa G.; Giannelli S.; Sottero B.; Leonarduzzi G.; A crosstalk between brain cholesterol oxidation and glucose metabolism in Alzheimer\u2019s disease. Front Neurosci 2019,13,556","journal-title":"Front Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"Tiwari S.","year":"2019","unstructured":"Tiwari S.; Atluri V.; Kaushik A.; Yndart A.; Nair M.; Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 2019,14,5541-5554","journal-title":"Int J Nanomedicine"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"Goedert M.","year":"2015","unstructured":"Goedert M.; Alzheimer\u2019s and Parkinson\u2019s diseases: The prion concept in relation to assembled A\u03b2 tau, and \u03b1-synuclein. Science 2015,349(6248),1255555","journal-title":"Science"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"Murphy M.P.","year":"2010","unstructured":"Murphy M.P.; LeVine H.; Alzheimer\u2019s disease and the amyloid-beta peptide. J Alzheimers Dis 2010,19(1),311-323","journal-title":"J Alzheimers Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"Selkoe D.J.","year":"2016","unstructured":"Selkoe D.J.; Hardy J.; The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 2016,8(6),595-608","journal-title":"EMBO Mol Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnins.2018.00025","volume":"12","author":"Kametani F.","year":"2018","unstructured":"Kametani F.; Hasegawa M.; Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Front Neurosci 2018,12,25","journal-title":"Front Neurosci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","volume":"41","author":"Maccioni R.B.","year":"2010","unstructured":"Maccioni R.B.; Far\u00edas G.; Morales I.; Navarrete L.; The revitalized tau hypothesis on Alzheimer\u2019s disease. Arch Med Res 2010,41(3),226-231","journal-title":"Arch Med Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","volume":"163","author":"Muralidar S.","year":"2020","unstructured":"Muralidar S.; Ambi S.V.; Sekaran S.; Thirumalai D.; Palaniappan B.; Role of tau protein in Alzheimer\u2019s disease: The prime pathological player. Int J Biol Macromol 2020,163,1599-1617","journal-title":"Int J Biol Macromol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","volume":"16","author":"Xia Y.","year":"2021","unstructured":"Xia Y.; Prokop S.; Giasson B.I.; \u201cDon\u2019t Phos Over Tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol Neurodegener 2021,16(1),37","journal-title":"Mol Neurodegener"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"338ra66","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"Brier M.R.","year":"2016","unstructured":"Brier M.R.; Gordon B.; Friedrichsen K.; Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med 2016,8(338),338ra66","journal-title":"Sci Transl Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fimmu.2020.00293","volume":"11","author":"Barron M.R.","year":"2020","unstructured":"Barron M.R.; Gartlon J.; Dawson L.A.; Atkinson P.J.; Pardon M.C.; Increasing tau 4r tau levels exacerbates hippocampal tau hyperphosphorylation in the htau model of tauopathy but also tau dephosphorylation following acute systemic inflammation. Front Immunol 2020,11,293","journal-title":"Front Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"Johnson K.A.","year":"2016","unstructured":"Johnson K.A.; Schultz A.; Betensky R.A.; Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 2016,79(1),110-119","journal-title":"Ann Neurol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2174\/092986708785909111","volume":"15","author":"Gong C.X.","year":"2008","unstructured":"Gong C.X.; Iqbal K.; Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Curr Med Chem 2008,15(23),2321-2328","journal-title":"Curr Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.parkreldis.2015.09.020","volume":"22","author":"Irwin D.J.","year":"2016","unstructured":"Irwin D.J.; Tauopathies as clinicopathological entities. Parkinsonism Relat Disord 2016,22(S1),S29-S33","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1007\/s12035-021-02626-0","volume":"59","author":"Jiao Y.N.","year":"2022","unstructured":"Jiao Y.N.; Zhang J.S.; Qiao W.J.; Kai-xin-san inhibits tau pathology and neuronal apoptosis in aged SAMP8 mice. Mol Neurobiol 2022,59(5),3294-3309","journal-title":"Mol Neurobiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1749-6632.2000.tb06370.x","volume":"903","author":"Blass JP","year":"2000","unstructured":"Blass JP; Sheu RKF; Gibson G; Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci 2000,903(1 VASCULAR FACT),204-221","journal-title":"Ann N Y Acad Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3390\/ijms23073785","volume":"23","author":"Ardanaz C.G.","year":"2022","unstructured":"Ardanaz C.G.; Ram\u00edrez M.J.; Solas M.; Brain metabolic alterations in Alzheimer\u2019s disease. Int J Mol Sci 2022,23(7),3785","journal-title":"Int J Mol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","volume":"100","author":"Yin F.","year":"2016","unstructured":"Yin F.; Sancheti H.; Patil I.; Cadenas E.; Energy metabolism and inflammation in brain aging and Alzheimer\u2019s disease. Free Radic Biol Med 2016,100,108-122","journal-title":"Free Radic Biol Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/B0-12-226694-3\/00103-4","author":"Cox S.","year":"2005","unstructured":"Cox S.; ENERGY Metabolism. Caballero B., Ed. Encyclopedia of Human Nutrition 2005,106-114","journal-title":"Encyclopedia of Human Nutrition"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/B978-0-12-803550-4.00013-6","author":"Blanco A.","year":"2017","unstructured":"Blanco A.; Blanco G.; Metabolism. Medical Biochemistry 2017,275-281","journal-title":"Medical Biochemistry"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00019.2005","volume":"86","author":"Roberts S.B.","year":"2006","unstructured":"Roberts S.B.; Rosenberg I.; Nutrition and aging: changes in the regulation of energy metabolism with aging. Physiol Rev 2006,86(2),651-667","journal-title":"Physiol Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.bbamcr.2010.08.011","volume":"1813","author":"Mason E.F.","year":"2011","unstructured":"Mason E.F.; Rathmell J.C.; Cell metabolism: An essential link between cell growth and apoptosis. Biochim Biophys Acta Mol Cell Res 2011,1813(4),645-654","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1250256","DOI":"10.1126\/science.1250256","volume":"345","author":"Green D.R.","year":"2014","unstructured":"Green D.R.; Galluzzi L.; Kroemer G.; Metabolic control of cell death. Science 2014,345(6203),1250256","journal-title":"Science"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/nu9060638","volume":"9","author":"Burgeiro A.","year":"2017","unstructured":"Burgeiro A.; Cerqueira M.; Varela-Rodr\u00edguez B.; Glucose and lipid dysmetabolism in a rat model of prediabetes induced by a high-sucrose diet. Nutrients 2017,9(6),638","journal-title":"Nutrients"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/1871530319666191009161228","volume":"20","author":"Onaolapo A.Y.","year":"2020","unstructured":"Onaolapo A.Y.; Adebisi E.O.; Adeleye A.E.; Olofinnade A.T.; Onaolapo O.J.; Dietary melatonin protects against behavioural, metabolic, oxidative, and organ morphological changes in mice that are fed high-fat, high-sugar diet. Endocr Metab Immune Disord Drug Targets 2020,20(4),570-583","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1389201020666191011144930","volume":"21","author":"Onaolapo O.J.","year":"2020","unstructured":"Onaolapo O.J.; Adeyemi O.I.; Amujoyegbe O.J.; Fasola E.A.; Olofinnade A.T.; Onaolapo A.Y.; High dietary fat modulates neurobehavioural effect of lopinavir\/ritonavir in mice. Curr Pharm Biotechnol 2020,21(2),158-168","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2174\/1871530320666200821155005","volume":"21","author":"Olofinnade A.T.","year":"2021","unstructured":"Olofinnade A.T.; Alawode A.; Onaolapo A.Y.; Onaolapo O.J.; Lepidium meyenii Supplemented diet modulates neurobehavioral and biochemical parameters in mice fed high-fat high-sugar diet. Endocr Metab Immune Disord Drug Targets 2021,21(7),1333-1343","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"Mergenthaler P.","year":"2013","unstructured":"Mergenthaler P.; Lindauer U.; Dienel G.A.; Meisel A.; Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 2013,36(10),587-597","journal-title":"Trends Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fphys.2019.00457","volume":"10","author":"Lundqvist M.H.","year":"2019","unstructured":"Lundqvist M.H.; Almby K.; Abrahamsson N.; Eriksson J.W.; Is the brain a key player in glucose regulation and development of type 2 diabetes? Front Physiol 2019,10,457","journal-title":"Front Physiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2174\/1570159X18666201015161919","volume":"19","author":"Onaolapo A.Y.","year":"2021","unstructured":"Onaolapo A.Y.; Onaolapo O.J.; Peripheral and central glutamate dyshomeostasis in neurodegenerative disorders. Curr Neuropharmacol 2021,19(7),1069-1089","journal-title":"Curr Neuropharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnmol.2018.00216","volume":"11","author":"Watts M.E.","year":"2018","unstructured":"Watts M.E.; Pocock R.; Claudianos C.; Brain energy and oxygen metabolism: emerging role in normal function and disease. Front Mol Neurosci 2018,11,216","journal-title":"Front Mol Neurosci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1038\/emm.2016.4","volume":"48","author":"Roh E.","year":"2016","unstructured":"Roh E.; Song D.K.; Kim M.S.; Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism. Exp Mol Med 2016,48(3),e216","journal-title":"Exp Mol Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"836196","DOI":"10.3389\/fcell.2022.836196","volume":"10","author":"Ondaro J.","year":"2022","unstructured":"Ondaro J.; Hernandez-Eguiazu H.; Garciandia-Arcelus M.; Defects of nutrient signaling and autophagy in neurodegeneration. Front Cell Dev Biol 2022,10,836196","journal-title":"Front Cell Dev Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnene.2011.00009","volume":"3","author":"Ivanov A.","year":"2011","unstructured":"Ivanov A.; Zilberter Y.; Critical state of energy metabolism in brain slices: the principal role of oxygen delivery and energy substrates in shaping neuronal activity. Front Neuroenergetics 2011,3,9","journal-title":"Front Neuroenergetics"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"8200","DOI":"10.1523\/JNEUROSCI.1157-19.2019","volume":"39","author":"Rangaraju V.","year":"2019","unstructured":"Rangaraju V.; Lewis T.L.; Hirabayashi Y.; Pleiotropic mitochondria: the influence of mitochondria on neuronal development and disease. J Neurosci 2019,39(42),8200-8208","journal-title":"J Neurosci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fncom.2019.00049","volume":"13","author":"Vergara R.C.","year":"2019","unstructured":"Vergara R.C.; Jaramillo-Riveri S.; Luarte A.; The energy homeostasis principle: neuronal energy regulation drives local network dynamics generating behavior. Front Comput Neurosci 2019,13,49","journal-title":"Front Comput Neurosci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrn3745","volume":"15","author":"Morton G.J.","year":"2014","unstructured":"Morton G.J.; Meek T.H.; Schwartz M.W.; Neurobiology of food intake in health and disease. Nat Rev Neurosci 2014,15(6),367-378","journal-title":"Nat Rev Neurosci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.physiol.70.120806.095256","volume":"70","author":"Sandoval D.","year":"2008","unstructured":"Sandoval D.; Cota D.; Seeley R.J.; The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu Rev Physiol 2008,70(1),513-535","journal-title":"Annu Rev Physiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.coph.2009.10.006","volume":"9","author":"Kleinridders A.","year":"2009","unstructured":"Kleinridders A.; K\u00f6nner A.C.; Br\u00fcning J.C.; CNS-targets in control of energy and glucose homeostasis. Curr Opin Pharmacol 2009,9(6),794-804","journal-title":"Curr Opin Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"787470","DOI":"10.3389\/fnut.2021.787470","volume":"8","author":"Gutierrez-Aguilar R.","year":"2021","unstructured":"Gutierrez-Aguilar R.; Grayson B.E.; Kim D.H.; CNS GNPDA2 does not control appetite, but regulates glucose homeostasis. Front Nutr 2021,8,787470","journal-title":"Front Nutr"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1530\/EJE-21-0277","volume":"185","author":"Nogueiras R.","year":"2021","unstructured":"Nogueiras R.; Mechanisms in endocrinology: The gut\u2013brain axis: regulating energy balance independent of food intake. Eur J Endocrinol 2021,185(3),R75-R91","journal-title":"Eur J Endocrinol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1126\/science.1104344","volume":"307","author":"Schwartz M.W.","year":"2005","unstructured":"Schwartz M.W.; Porte D.; Diabetes, obesity, and the brain. Science 2005,307(5708),375-379","journal-title":"Science"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1053\/j.gastro.2007.03.049","volume":"132","author":"Cota D.","year":"2007","unstructured":"Cota D.; Proulx K.; Seeley R.J.; The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology 2007,132(6),2158-2168","journal-title":"Gastroenterology"},{"key":"ref=64","author":"Nakrani M.N.","year":"2022","unstructured":"Nakrani M.N.; Wineland R.H.; Anjum F.;  Physiology, Glucose Metabolism 2022","journal-title":"Physiology, Glucose Metabolism"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrn3409","volume":"14","author":"Grayson B.E.","year":"2013","unstructured":"Grayson B.E.; Seeley R.J.; Sandoval D.A.; Wired on sugar: the role of the CNS in the regulation of glucose homeostasis. Nat Rev Neurosci 2013,14(1),24-37","journal-title":"Nat Rev Neurosci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/jcbfm.2009.35","volume":"29","author":"van Hall G.","year":"2009","unstructured":"van Hall G.; St\u00f8mstad M.; Rasmussen P.; Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab 2009,29(6),1121-1129","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/metabo11120813","volume":"11","author":"Hashimoto T.","year":"2021","unstructured":"Hashimoto T.; Tsukamoto H.; Ando S.; Ogoh S.; Effect of exercise on brain health: The potential role of lactate as a myokine. Metabolites 2021,11(12),813","journal-title":"Metabolites"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ijms21041505","volume":"21","author":"Kao Y.C.","year":"2020","unstructured":"Kao Y.C.; Ho P.C.; Tu Y.K.; Jou I.M.; Tsai K.J.; Lipids and Alzheimer\u2019s disease. Int J Mol Sci 2020,21(4),1505","journal-title":"Int J Mol Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2017.00060","volume":"8","author":"Bruce K.D.","year":"2017","unstructured":"Bruce K.D.; Zsombok A.; Eckel R.H.; Lipid processing in the brain: A key regulator of systemic metabolism. Front Endocrinol 2017,8,60","journal-title":"Front Endocrinol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12031-007-0060-1","volume":"33","author":"Hamilton J.A.","year":"2007","unstructured":"Hamilton J.A.; Hillard C.J.; Spector A.A.; Watkins P.A.; Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders. J Mol Neurosci 2007,33(1),2-11","journal-title":"J Mol Neurosci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.irn.2015.05.008","volume":"122","author":"Naud\u00ed A.","year":"2015","unstructured":"Naud\u00ed A.; Cabr\u00e9 R.; Jov\u00e9 M.; Lipidomics of human brain aging and Alzheimer\u2019s disease pathology. Int Rev Neurobiol 2015,122,133-189","journal-title":"Int Rev Neurobiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"101082","DOI":"10.1016\/j.redox.2018.101082","volume":"23","author":"Jov\u00e9 M.","year":"2019","unstructured":"Jov\u00e9 M.; Pradas I.; Dominguez-Gonzalez M.; Ferrer I.; Pamplona R.; Lipids and lipoxidation in human brain aging. Mitochondrial ATP-synthase as a key lipoxidation target. Redox Biol 2019,23,101082","journal-title":"Redox Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fncel.2019.00212","volume":"13","author":"Barber C.N.","year":"2019","unstructured":"Barber C.N.; Raben D.M.; Lipid metabolism crosstalk in the brain: Glia and neurons. Front Cell Neurosci 2019,13,212","journal-title":"Front Cell Neurosci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2016.12.015","volume":"84","author":"Romano A.","year":"2017","unstructured":"Romano A.; Koczwara J.B.; Gallelli C.A.; Fats for thoughts: An update on brain fatty acid metabolism. Int J Biochem Cell Biol 2017,84,40-45","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnmol.2018.00010","volume":"11","author":"Tracey T.J.","year":"2018","unstructured":"Tracey T.J.; Steyn F.J.; Wolvetang E.J.; Ngo S.T.; Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front Mol Neurosci 2018,11,10","journal-title":"Front Mol Neurosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0022-2275(20)31629-1","volume":"42","author":"Rapoport S.I.","year":"2001","unstructured":"Rapoport S.I.; Chang M.C.J.; Spector A.A.; Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 2001,42(5),678-685","journal-title":"J Lipid Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1385\/JMN:16:2-3:167","volume":"16","author":"Smith Q.R.","year":"2001","unstructured":"Smith Q.R.; Nagura H.; Fatty acid uptake and incorporation in brain: studies with the perfusion model. J Mol Neurosci 2001,16(2-3),167-172","journal-title":"J Mol Neurosci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1021\/bi047292r","volume":"44","author":"Murphy E.J.","year":"2005","unstructured":"Murphy E.J.; Owada Y.; Kitanaka N.; Kondo H.; Glatz J.F.C.; Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice. Biochemistry 2005,44(16),6350-6360","journal-title":"Biochemistry"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"R655","DOI":"10.1152\/ajpregu.00223.2009","volume":"297","author":"Le Foll C.","year":"2009","unstructured":"Le Foll C.; Irani B.G.; Magnan C.; Dunn-Meynell A.A.; Levin B.E.; Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing. Am J Physiol Regul Integr Comp Physiol 2009,297(3),R655-R664","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.plefa.2011.04.007","volume":"85","author":"Mitchell R.W.","year":"2011","unstructured":"Mitchell R.W.; Hatch G.M.; Fatty acid transport into the brain: Of fatty acid fables and lipid tails. Prostaglandins Leukot Essent Fatty Acids 2011,85(5),293-302","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2337\/db13-1090","volume":"63","author":"Le Foll C.","year":"2014","unstructured":"Le Foll C.; Dunn-Meynell A.A.; Miziorko H.M.; Levin B.E.; Regulation of hypothalamic neuronal sensing and food intake by ketone bodies and fatty acids. Diabetes 2014,63(4),1259-1269","journal-title":"Diabetes"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"R872","DOI":"10.1152\/ajpregu.00015.2015","volume":"308","author":"Le Foll C.","year":"2015","unstructured":"Le Foll C.; Dunn-Meynell A.A.; Miziorko H.M.; Levin B.E.; Role of VMH ketone bodies in adjusting caloric intake to increased dietary fat content in DIO and DR rats. Am J Physiol Regul Integr Comp Physiol 2015,308(10),R872-R878","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jnc.13035","volume":"133","author":"Bouyakdan K.","year":"2015","unstructured":"Bouyakdan K.; Ta\u00efb B.; Budry L.; A novel role for central ACBP\/DBI as a regulator of long-chain fatty acid metabolism in astrocytes. J Neurochem 2015,133(2),253-265","journal-title":"J Neurochem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/glia.22902","volume":"64","author":"Ebrahimi M.","year":"2016","unstructured":"Ebrahimi M.; Yamamoto Y.; Sharifi K.; Astrocyte-expressed FABP7 regulates dendritic morphology and excitatory synaptic function of cortical neurons. Glia 2016,64(1),48-62","journal-title":"Glia"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"Zhang J.","year":"2015","unstructured":"Zhang J.; Liu Q.; Cholesterol metabolism and homeostasis in the brain. Protein Cell 2015,6(4),254-264","journal-title":"Protein Cell"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-4159.1990.tb01889.x","volume":"54","author":"S\u00f6derberg M.","year":"1990","unstructured":"S\u00f6derberg M.; Edlund C.; Kristensson K.; Dallner G.; Lipid compositions of different regions of the human brain during aging. J Neurochem 1990,54(2),415-423","journal-title":"J Neurochem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1046\/j.1471-4159.1994.63051802.x","volume":"63","author":"Svennerholm L.","year":"1994","unstructured":"Svennerholm L.; Bostr\u00f6m K.; Jungbjer B.; Olsson L.; Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem 1994,63(5),1802-1811","journal-title":"J Neurochem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1242\/jcs.060681","volume":"123","author":"Linetti A.","year":"2010","unstructured":"Linetti A.; Fratangeli A.; Taverna E.; Cholesterol reduction impairs exocytosis of synaptic vesicles. J Cell Sci 2010,123(4),595-605","journal-title":"J Cell Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","volume":"30","author":"Liu Q.","year":"2010","unstructured":"Liu Q.; Trotter J.; Zhang J.; Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci 2010,30(50),17068-17078","journal-title":"J Neurosci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JAD-2011-101608","volume":"24","author":"Igarashi M.","year":"2011","unstructured":"Igarashi M.; Ma K.; Gao F.; Kim H.W.; Rapoport S.I.; Rao J.S.; Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer\u2019s disease prefrontal cortex. J Alzheimers Dis 2011,24(3),507-517","journal-title":"J Alzheimers Dis"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40478-021-01216-4","volume":"9","author":"Emre C.","year":"2021","unstructured":"Emre C.; Do K.V.; Jun B.; Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer\u2019s disease. Acta Neuropathol Commun 2021,9(1),116","journal-title":"Acta Neuropathol Commun"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1023\/A:1011603916962","volume":"26","author":"Pettegrew J.W.","year":"2001","unstructured":"Pettegrew J.W.; Panchalingam K.; Hamilton R.L.; McClure R.J.; Brain membrane phospholipid alterations in Alzheimer\u2019s disease. Neurochem Res 2001,26(7),771-782","journal-title":"Neurochem Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1022457605436","volume":"23","author":"Prasad M.R.","year":"1998","unstructured":"Prasad M.R.; Lovell M.A.; Yatin M.; Dhillon H.; Markesbery W.R.; Regional membrane phospholipid alterations in Alzheimer\u2019s disease. Neurochem Res 1998,23(1),81-88","journal-title":"Neurochem Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-2012-110629","volume":"29","author":"Cunnane S.C.","year":"2012","unstructured":"Cunnane S.C.; Schneider J.A.; Tangney C.; Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis 2012,29(3),691-697","journal-title":"J Alzheimers Dis"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e12538","DOI":"10.1371\/journal.pone.0012538","volume":"5","author":"Astarita G.","year":"2010","unstructured":"Astarita G.; Jung K.M.; Berchtold N.C.; Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer\u2019s disease. PLoS One 2010,5(9),e12538","journal-title":"PLoS One"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"105143","DOI":"10.1016\/j.neuint.2021.105143","volume":"149","author":"Ooi K.L.M.","year":"2021","unstructured":"Ooi K.L.M.; Vacy K.; Boon W.C.; Fatty acids and beyond: Age and Alzheimer\u2019s disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition. Neurochem Int 2021,149,105143","journal-title":"Neurochem Int"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4239\/wjd.v9.i7.99","volume":"9","author":"Onaolapo A.Y.","year":"2018","unstructured":"Onaolapo A.Y.; Onaolapo O.J.; Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin\u2019s roles in prophylaxis and management. World J Diabetes 2018,9(7),99-114","journal-title":"World J Diabetes"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2174\/1573399815666191106104941","volume":"16","author":"Onaolapo A.Y.","year":"2020","unstructured":"Onaolapo A.Y.; Onaolapo O.J.; African Plants with Antidiabetic Potentials: Beyond Glycaemic Control to Central Nervous System Benefits. Curr Diabetes Rev 2020,16(5),419-437","journal-title":"Curr Diabetes Rev"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1573399814666181031103930","volume":"16","author":"Onaolapo A.Y.","year":"2019","unstructured":"Onaolapo A.Y.; Onaolapo O.J.; Nutraceuticals and diet-based phytochemicals in type 2 diabetes mellitus: From whole food to components with defined roles and mechanisms. Curr Diabetes Rev 2019,16(1),12-25","journal-title":"Curr Diabetes Rev"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.3390\/ijms23042397","volume":"23","author":"Maida C.D.","year":"2022","unstructured":"Maida C.D.; Daidone M.; Pacinella G.; Norrito R.L.; Pinto A.; Tuttolomondo A.; Diabetes and ischemic stroke: An old and new relationship an overview of the close interaction between these diseases. Int J Mol Sci 2022,23(4),2397","journal-title":"Int J Mol Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.3390\/ijms23052404","volume":"23","author":"Pinto R.S.","year":"2022","unstructured":"Pinto R.S.; Minanni C.A.; de Ara\u00fajo Lira A.L.; Passarelli M.; Advanced glycation end products: A sweet flavor that embitters cardiovascular disease. Int J Mol Sci 2022,23(5),2404","journal-title":"Int J Mol Sci"},{"key":"ref=102","first-page":"9","volume":"105","author":"Biesenbach G.","year":"1989","unstructured":"Biesenbach G.; Fettstoffwechselst\u00f6rungen bei diabetes mellitus. Wien Med Wochenschr Suppl 1989,105,9-17","journal-title":"Wien Med Wochenschr Suppl"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1152\/physrev.00024.2006","volume":"87","author":"Savage D.B.","year":"2007","unstructured":"Savage D.B.; Petersen K.F.; Shulman G.I.; Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007,87(2),507-520","journal-title":"Physiol Rev"},{"key":"ref=104","first-page":"32","volume":"25","author":"Verg\u00e8s B.L.","year":"1999","unstructured":"Verg\u00e8s B.L.; Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab 1999,25(S3),32-40","journal-title":"Diabetes Metab"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/TCRM.S134560","volume":"13","author":"Albai O.","year":"2017","unstructured":"Albai O.; Roman D.; Frandes M.; Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus. Ther Clin Risk Manag 2017,13,515-522","journal-title":"Ther Clin Risk Manag"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jacc.2008.09.055","volume":"53","author":"Orasanu G.","year":"2009","unstructured":"Orasanu G.; Plutzky J.; The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009,53(5),S35-S42","journal-title":"J Am Coll Cardiol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"108235","DOI":"10.1016\/j.diabres.2020.108235","volume":"165","author":"Mather K.J.","year":"2020","unstructured":"Mather K.J.; Bebu I.; Baker C.; Prevalence of microvascular and macrovascular disease in the glycemia reduction approaches in diabetes - A comparative effectiveness (GRADE) study cohort. Diabetes Res Clin Pract 2020,165,108235","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3389\/fendo.2019.00843","volume":"10","author":"Sinclair S.H.","year":"2019","unstructured":"Sinclair S.H.; Schwartz S.S.; Diabetic retinopathy\u2013an underdiagnosed and undertreated inflammatory, neuro-vascular complication of diabetes. Front Endocrinol 2019,10,843","journal-title":"Front Endocrinol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bbadis.2008.10.013","volume":"1792","author":"Wrighten S.A.","year":"2009","unstructured":"Wrighten S.A.; Piroli G.G.; Grillo C.A.; Reagan L.P.; A look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochim Biophys Acta Mol Basis Dis 2009,1792(5),444-453","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JAD-161192","volume":"59","author":"Bharadwaj P.","year":"2017","unstructured":"Bharadwaj P.; Wijesekara N.; Liyanapathirana M.; The link between type 2 diabetes and neurodegeneration: Roles for amyloid-\u03b2 amylin, and tau proteins. J Alzheimers Dis 2017,59(2),421-432","journal-title":"J Alzheimers Dis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2741\/4906","volume":"26","author":"Olofinnade A.T.","year":"2021","unstructured":"Olofinnade A.T.; Onaolapo A.Y.; Onaolapo O.J.; Corylus avellana L. modulates neurobehaviour and brain chemistry following high-fat diet. Front Biosci 2021,26(3),537-551","journal-title":"Front Biosci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/17512433.2017.1293521","volume":"10","author":"Hamed S.A.","year":"2017","unstructured":"Hamed S.A.; Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol 2017,10(4),409-428","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejphar.2004.02.041","volume":"490","author":"McEwen B.S.","year":"2004","unstructured":"McEwen B.S.; Reagan L.P.; Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 2004,490(1-3),13-24","journal-title":"Eur J Pharmacol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"Koepsell H.","year":"2020","unstructured":"Koepsell H.; Glucose transporters in brain in health and disease. Pflugers Arch 2020,472(9),1299-1343","journal-title":"Pflugers Arch"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"147747","DOI":"10.1016\/j.brainres.2021.147747","volume":"1776","author":"Craven R.J.","year":"2022","unstructured":"Craven R.J.; Frazier H.N.; Thibault O.; Dependence of glucose transport on autophagy and GAPDH activity. Brain Res 2022,1776,147747","journal-title":"Brain Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0006-8993(02)03675-2","volume":"957","author":"Saravia F.E.","year":"2002","unstructured":"Saravia F.E.; Revsin Y.; Gonzalez Deniselle M.C.; Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 2002,957(2),345-353","journal-title":"Brain Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/glia.20068","volume":"48","author":"Coleman E.","year":"2004","unstructured":"Coleman E.; Judd R.; Hoe L.; Dennis J.; Posner P.; Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 2004,48(2),166-178","journal-title":"Glia"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1152\/ajpendo.00118.2005","volume":"290","author":"Zelena D.","year":"2006","unstructured":"Zelena D.; Filaretova L.; Mergl Z.; Barna I.; T\u00f3th Z.E.; Makara G.B.; Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats. Am J Physiol Endocrinol Metab 2006,290(2),E243-E250","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000135625","volume":"15","author":"Beauquis J.","year":"2008","unstructured":"Beauquis J.; Homo-Delarche F.; Revsin Y.; De Nicola A.F.; Saravia F.; Brain alterations in autoimmune and pharmacological models of diabetes mellitus: focus on hypothalamic-pituitary-adrenocortical axis disturbances. Neuroimmunomodulation 2008,15(1),61-67","journal-title":"Neuroimmunomodulation"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.expneurol.2007.11.009","volume":"210","author":"Beauquis J.","year":"2008","unstructured":"Beauquis J.; Saravia F.; Coulaud J.; Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse. Exp Neurol 2008,210(2),359-367","journal-title":"Exp Neurol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neures.2010.08.012","volume":"68","author":"Guo J.","year":"2010","unstructured":"Guo J.; Yu C.; Li H.; Impaired neural stem\/progenitor cell proliferation in streptozotocin-induced and spontaneous diabetic mice. Neurosci Res 2010,68(4),329-336","journal-title":"Neurosci Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"684","DOI":"10.17179\/excli2015-252","volume":"14","author":"Rizvi S.M.","year":"2015","unstructured":"Rizvi S.M.; Shaikh S.; Waseem S.M.; Role of anti-diabetic drugs as therapeutic agents in Alzheimer\u2019s disease. EXCLI J 2015,14,684-696","journal-title":"EXCLI J"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2337\/diacare.13.1.16","volume":"13","author":"Reaven G.M.","year":"1990","unstructured":"Reaven G.M.; Thompson L.W.; Nahum D.; Haskins E.; Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990,13(1),16-21","journal-title":"Diabetes Care"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2337\/dc08-1153","volume":"32","author":"Cukierman-Yaffe T.","year":"2009","unstructured":"Cukierman-Yaffe T.; Gerstein H.C.; Williamson J.D.; Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009,32(2),221-226","journal-title":"Diabetes Care"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1017\/S1041610202008116","volume":"13","author":"Thomas V.S.","year":"2001","unstructured":"Thomas V.S.; Darvesh S.; MacKnight C.; Rockwood K.; Estimating the prevalence of dementia in elderly people: a comparison of the Canadian Study of Health and Aging and National Population Health Survey approaches. Int Psychogeriatr 2001,13(S1)(Suppl. 1),169-175","journal-title":"Int Psychogeriatr"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.bbadis.2008.12.003","volume":"1792","author":"S Roriz-Filho J","year":"2009","unstructured":"S Roriz-Filho J; S\u00e1-Roriz TM; Rosset I; (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009,1792(5),432-443","journal-title":"Biochim Biophys Acta"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.diabet.2014.02.002","volume":"40","author":"Bordier L.","year":"2014","unstructured":"Bordier L.; Doucet J.; Boudet J.; Bauduceau B.; Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab 2014,40(5),331-337","journal-title":"Diabetes Metab"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"Ott A.","year":"1999","unstructured":"Ott A.; Stolk R.P.; van Harskamp F.; Pols H.A.P.; Hofman A.; Breteler M.M.B.; Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999,53(9),1937-1942","journal-title":"Neurology"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2337\/db09-1600","volume":"59","author":"Seaquist E.R.","year":"2010","unstructured":"Seaquist E.R.; The final frontier: how does diabetes affect the brain? Diabetes 2010,59(1),4-5","journal-title":"Diabetes"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/dmrr.1112","volume":"26","author":"Reijmer Y.D.","year":"2010","unstructured":"Reijmer Y.D.; van den Berg E.; Ruis C.; Jaap Kappelle L.; Biessels G.J.; Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010,26(7),507-519","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bcp.2012.05.007","volume":"84","author":"Williamson R.","year":"2012","unstructured":"Williamson R.; McNeilly A.; Sutherland C.; Insulin resistance in the brain: An old-age or new-age problem? Biochem Pharmacol 2012,84(6),737-745","journal-title":"Biochem Pharmacol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jalz.2013.12.008","volume":"10","author":"Steculorum S.M.","year":"2014","unstructured":"Steculorum S.M.; Solas M.; Br\u00fcning J.C.; The paradox of neuronal insulin action and resistance in the development of aging\u2010associated diseases. Alzheimers Dement 2014,10(1S)(Suppl.),S3-S11","journal-title":"Alzheimers Dement"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12993-015-0069-5","volume":"11","author":"Zhou Y.","year":"2015","unstructured":"Zhou Y.; Zhao Y.; Xie H.; Wang Y.; Liu L.; Yan X.; Alteration in amyloid \u03b242, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid \u03b242 with changes in glucose metabolism. Behav Brain Funct 2015,11(1),24","journal-title":"Behav Brain Funct"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","volume":"339","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Huang N.; Yan F.; Diabetes mellitus and Alzheimer\u2019s disease: GSK-3\u03b2 as a potential link. Behav Brain Res 2018,339,57-65","journal-title":"Behav Brain Res"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.2040-1124.2012.00234.x","volume":"3","author":"Kawamura T.","year":"2012","unstructured":"Kawamura T.; Umemura T.; Hotta N.; Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig 2012,3(5),413-423","journal-title":"J Diabetes Investig"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/archneurol.2009.27","volume":"66","author":"Craft S.","year":"2009","unstructured":"Craft S.; The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 2009,66(3),300-305","journal-title":"Arch Neurol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.008","volume":"84","author":"Verdile G.","year":"2015","unstructured":"Verdile G.; Fuller S.J.; Martins R.N.; The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 2015,84,22-38","journal-title":"Neurobiol Dis"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"e86284","DOI":"10.1371\/journal.pone.0086284","volume":"9","author":"Cui X.","year":"2014","unstructured":"Cui X.; Abduljalil A.; Manor B.D.; Peng C.K.; Novak V.; Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes. PLoS One 2014,9(1),e86284","journal-title":"PLoS One"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.18632\/oncotarget.23284","volume":"9","author":"Zhao X.","year":"2018","unstructured":"Zhao X.; Han Q.; Lv Y.; Sun L.; Gang X.; Wang G.; Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies. Oncotarget 2018,9(7),7710-7726","journal-title":"Oncotarget"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00125-021-05634-w","volume":"65","author":"Sluiman A.J.","year":"2022","unstructured":"Sluiman A.J.; McLachlan S.; Forster R.B.; Strachan M.W.J.; Deary I.J.; Price J.F.; Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh type 2 diabetes study. Diabetologia 2022,65(3),467-476","journal-title":"Diabetologia"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1096\/fj.201700431R","volume":"31","author":"Wijesekara N.","year":"2017","unstructured":"Wijesekara N.; Ahrens R.; Sabale M.; Amyloid\u2010\u03b2 and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model. FASEB J 2017,31(12),5409-5418","journal-title":"FASEB J"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"978","DOI":"10.14336\/AD.2019.0910","volume":"11","author":"Ma W.X.","year":"2020","unstructured":"Ma W.X.; Tang J.; Lei Z.W.; Potential biochemical mechanisms of brain injury in diabetes mellitus. Aging Dis 2020,11(4),978-987","journal-title":"Aging Dis"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1111\/ejn.15619","volume":"56","author":"Cummings J.","year":"2022","unstructured":"Cummings J.; Ortiz A.; Castellino J.; Kinney J.; Diabetes: Risk factor and translational therapeutic implications for Alzheimer\u2019s disease. Eur J Neurosci Epub ahead of print2022,56(9),5727-5757","journal-title":"Eur J Neurosci"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","volume":"27","author":"Qiu W.","year":"2006","unstructured":"Qiu W.; Folstein M.; Insulin, insulin-degrading enzyme and amyloid-\u03b2 peptide in Alzheimer\u2019s disease: review and hypothesis. Neurobiol Aging 2006,27(2),190-198","journal-title":"Neurobiol Aging"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2008.02.048","volume":"585","author":"Luchsinger J.A.","year":"2008","unstructured":"Luchsinger J.A.; Adiposity, hyperinsulinemia, diabetes and Alzheimer\u2019s disease. Eur J Pharmacol 2008,585(1),119-129","journal-title":"Eur J Pharmacol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","volume":"75","author":"Schrijvers E.M.C.","year":"2010","unstructured":"Schrijvers E.M.C.; Witteman J.C.M.; Sijbrands E.J.G.; Hofman A.; Koudstaal P.J.; Breteler M.M.B.; Insulin metabolism and the risk of Alzheimer disease: The rotterdam study. Neurology 2010,75(22),1982-1987","journal-title":"Neurology"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","volume":"75","author":"Matsuzaki T.","year":"2010","unstructured":"Matsuzaki T.; Sasaki K.; Tanizaki Y.; Insulin resistance is associated with the pathology of Alzheimer disease: The hisayama study. Neurology 2010,75(9),764-770","journal-title":"Neurology"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/156720512799015037","volume":"9","author":"de la Monte S.M.","year":"2012","unstructured":"de la Monte S.M.; Brain insulin resistance and deficiency as therapeutic targets in Alzheimer\u2019s disease. Curr Alzheimer Res 2012,9(1),35-66","journal-title":"Curr Alzheimer Res"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/BST20120080","volume":"40","author":"O\u2019Neill C.","year":"2012","unstructured":"O\u2019Neill C.; Kiely A.P.; Coakley M.F.; Manning S.; Long-Smith C.M.; Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer\u2019s disease. Biochem Soc Trans 2012,40(4),721-727","journal-title":"Biochem Soc Trans"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12035-011-8229-6","volume":"46","author":"Schi\u00f6th H.B.","year":"2012","unstructured":"Schi\u00f6th H.B.; Craft S.; Brooks S.J.; Frey W.H.; Benedict C.; Brain insulin signaling and Alzheimer\u2019s disease: current evidence and future directions. Mol Neurobiol 2012,46(1),4-10","journal-title":"Mol Neurobiol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.metabol.2013.08.007","volume":"62","author":"Park S","year":"2013","unstructured":"Park S; Kim DS; Kang S; Moon NR; \u03b2-Amyloid-induced cognitive dysfunction impairs glucose homeostasis by increasing insulin resistance and decreasing \u03b2-cell mass in non-diabetic and diabetic rats. Metabolism 2013,62(12),1749-1760","journal-title":"Metabolism"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"afab231","DOI":"10.1093\/ageing\/afab231","volume":"51","author":"Reinke C.","year":"2022","unstructured":"Reinke C.; Buchmann N.; Fink A.; Tegeler C.; Demuth I.; Doblhammer G.; Diabetes duration and the risk of dementia: a cohort study based on German health claims data. Age Ageing 2022,51(1),afab231","journal-title":"Age Ageing"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.mehy.2005.01.016","volume":"64","author":"Yamagishi S.","year":"2005","unstructured":"Yamagishi S.; Nakamura K.; Inoue H.; Kikuchi S.; Takeuchi M.; Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer\u2019s disease. Med Hypotheses 2005,64(6),1205-1207","journal-title":"Med Hypotheses"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1096\/fj.05-5478fje","volume":"20","author":"Jia X.","year":"2006","unstructured":"Jia X.; Olson D.J.H.; Ross A.R.S.; Structural and functional changes in human insulin induced by methylglyoxal. FASEB J 2006,20(9),1555-1557","journal-title":"FASEB J"},{"key":"ref=155","first-page":"277","volume":"16","author":"Alagiakrishnan K.","year":"2013","unstructured":"Alagiakrishnan K.; Sankaralingam S.; Ghosh M.; Mereu L.; Senior P.; Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer\u2019s disease. Discov Med 2013,16(90),277-286","journal-title":"Discov Med"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1177\/1535370217711440","volume":"242","author":"Ahmed A.S.","year":"2017","unstructured":"Ahmed A.S.; Elgharabawy R.M,; AL-Najjar AH. Ameliorating effect of anti-Alzheimer\u2019s drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer\u2019s disease. Exp Biol Med (Maywood) 2017,242(13),1335-1344","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","volume":"34","author":"Markowicz-Piasecka M.","year":"2017","unstructured":"Markowicz-Piasecka M.; Sikora J.; Szyd\u0142owska A; Skupie\u0144 A; Mikiciuk-Olasik E; Huttunen KM.; Metformin - a future therapy for neurodegenerative diseases: Theme: Drug discovery, development and delivery in Alzheimer's disease. Pharm Res 2017,34(12),2614-2627","journal-title":"Pharm Res"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1533317519899546","author":"Akimoto H.","year":"2020","unstructured":"Akimoto H.; Negishi A.; Oshima S.; Antidiabetic drugs for the risk of Alzheimer disease in patients with type 2 DM using FAERS. Am J Alzheimers Dis Other Demen 2020,35","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000510677","volume":"49","author":"Mu\u00f1oz-Jim\u00e9nez M.","year":"2020","unstructured":"Mu\u00f1oz-Jim\u00e9nez M.; Zaarkti A.; Garc\u00eda-Arn\u00e9s J.A.; Garc\u00eda-Casares N.; Antidiabetic drugs in Alzheimer\u2019s disease and mild cognitive impairment: A systematic review. Dement Geriatr Cogn Disord 2020,49(5),423-434","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","volume":"77","author":"Craft S.","year":"2020","unstructured":"Craft S.; Raman R.; Chow T.W.; Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia. JAMA Neurol 2020,77(9),1099-1109","journal-title":"JAMA Neurol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1523\/JNEUROSCI.4082-13.2014","volume":"34","author":"Moln\u00e1r G.","year":"2014","unstructured":"Moln\u00e1r G.; Farag\u00f3 N.; Kocsis A.K.; GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex. J Neurosci 2014,34(4),1133-1137","journal-title":"J Neurosci"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27","author":"Freiherr J.","year":"2013","unstructured":"Freiherr J.; Hallschmid M.; Frey W.H.; Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS Drugs 2013,27(7),505-514","journal-title":"CNS Drugs"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","volume":"27","author":"Reger M.A.","year":"2006","unstructured":"Reger M.A.; Watson G.S.; Frey W.H.; Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype. Neurobiol Aging 2006,27(3),451-458","journal-title":"Neurobiol Aging"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","volume":"70","author":"Reger M.A.","year":"2008","unstructured":"Reger M.A.; Watson G.S.; Green P.S.; Intranasal insulin improves cognition and modulates -amyloid in early AD. Neurology 2008,70(6),440-448","journal-title":"Neurology"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1212\/01.wnl.0000344246.91081.2c","volume":"72","author":"Dhamoon M.S.","year":"2009","unstructured":"Dhamoon M.S.; Noble J.M.; Craft S.; Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2009,72(3),292-294","journal-title":"Neurology"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2174\/1389450111007011193","volume":"11","author":"Ferreira I.L.","year":"2010","unstructured":"Ferreira I.L.; Resende R.; Ferreiro E.; Rego A.C.; Pereira C.F.; Multiple defects in energy metabolism in Alzheimer\u2019s disease. Curr Drug Targets 2010,11(10),1193-1206","journal-title":"Curr Drug Targets"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"Craft S.","year":"2012","unstructured":"Craft S.; Baker L.D.; Montine T.J.; Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012,69(1),29-38","journal-title":"Arch Neurol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3233\/JAD-122308","volume":"35","author":"Claxton A.","year":"2013","unstructured":"Claxton A.; Baker L.D.; Wilkinson C.W.; Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer\u2019s disease. J Alzheimers Dis 2013,35(4),789-797","journal-title":"J Alzheimers Dis"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","volume":"62","author":"\u0141abuzek K","year":"2010","unstructured":"\u0141abuzek K; Suchy D; Gabryel B; Bielecka A; Liber S; Okopie\u0144 B.; Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep 2010,62(5),956-65","journal-title":"Pharmacol Rep"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","volume":"60","author":"Gupta A.","year":"2011","unstructured":"Gupta A.; Bisht B.; Dey C.S.; Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes. Neuropharmacology 2011,60(6),910-920","journal-title":"Neuropharmacology"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2315106","volume":"2020","author":"Lu X.Y.","year":"2020","unstructured":"Lu X.Y.; Huang S.; Chen Q.B.; Metformin Ameliorates A \u03b2 Pathology by Insulin-Degrading Enzyme in a Transgenic Mouse Model of Alzheimer\u2019s Disease. Oxid Med Cell Longev 2020,2020,1-10","journal-title":"Oxid Med Cell Longev"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"Hampel H.","year":"2021","unstructured":"Hampel H.; Vassar R.; De Strooper B.; The \u03b2-Secretase BACE1 in Alzheimer\u2019s Disease. Biol Psychiatry 2021,89(8),745-756","journal-title":"Biol Psychiatry"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","volume":"69","author":"Ou Z.","year":"2018","unstructured":"Ou Z.; Kong X.; Sun X.; Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice. Brain Behav Immun 2018,69,351-363","journal-title":"Brain Behav Immun"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"Foretz M.","year":"2014","unstructured":"Foretz M.; Guigas B.; Bertrand L.; Pollak M.; Viollet B.; Metformin: from mechanisms of action to therapies. Cell Metab 2014,20(6),953-966","journal-title":"Cell Metab"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1389203720666190819142746","volume":"21","author":"Yang L.","year":"2020","unstructured":"Yang L.; Jiang Y.; Shi L.; AMPK: Potential Therapeutic Target for Alzheimer\u2019s Disease. Curr Protein Pept Sci 2020,21(1),66-77","journal-title":"Curr Protein Pept Sci"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","volume":"101","author":"Chen F.","year":"2016","unstructured":"Chen F.; Dong R.R.; Zhong K.L.; Antidiabetic drugs restore abnormal transport of amyloid-\u03b2 across the blood\u2013brain barrier and memory impairment in db\/db mice. Neuropharmacology 2016,101,123-136","journal-title":"Neuropharmacology"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00213-016-4301-2","volume":"233","author":"Mostafa D.K.","year":"2016","unstructured":"Mostafa D.K.; Ismail C.A.; Ghareeb D.A.; Differential metformin dose-dependent effects on cognition in rats: role of Akt. Psychopharmacology (Berl) 2016,233(13),2513-2524","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1073\/pnas.0912793107","volume":"107","author":"Kickstein E.","year":"2010","unstructured":"Kickstein E.; Krauss S.; Thornhill P.; Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci USA 2010,107(50),21830-21835","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","volume":"101","author":"Li J.","year":"2012","unstructured":"Li J.; Deng J.; Sheng W.; Zuo Z.; Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 2012,101(4),564-574","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-020-00761-9","volume":"13","author":"Chen Y.","year":"2021","unstructured":"Chen Y.; Zhao S.; Fan Z.; Metformin attenuates plaque-associated tau pathology and reduces amyloid-\u03b2 burden in APP\/PS1 mice. Alzheimers Res Ther 2021,13(1),40","journal-title":"Alzheimers Res Ther"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1096\/fj.201802718R","volume":"33","author":"Zhang J.","year":"2019","unstructured":"Zhang J.; Lin Y.; Dai X.; Fang W.; Wu X.; Chen X.; Metformin treatment improves the spatial memory of aged mice in an APOE genotype\u2013dependent manner. FASEB J 2019,33(6),7748-7757","journal-title":"FASEB J"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3233\/JAD-181017","volume":"68","author":"Kuhla A.","year":"2019","unstructured":"Kuhla A.; Brichmann E.; R\u00fchlmann C.; Thiele R.; Meuth L.; Vollmar B.; Metformin therapy aggravates neurodegenerative processes in ApoE\u2013\/\u2013 mice. J Alzheimers Dis 2019,68(4),1415-1427","journal-title":"J Alzheimers Dis"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ejps.2013.05.023","volume":"49","author":"Huttunen K.M.","year":"2013","unstructured":"Huttunen K.M.; Lepp\u00e4nen J.; Laine K.; Veps\u00e4l\u00e4inen J.; Rautio J.; Convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin. Eur J Pharm Sci 2013,49(4),624-628","journal-title":"Eur J Pharm Sci"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1021\/jm900274q","volume":"52","author":"Huttunen K.M.","year":"2009","unstructured":"Huttunen K.M.; Mannila A.; Laine K.; The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption. J Med Chem 2009,52(14),4142-4148","journal-title":"J Med Chem"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"728315","DOI":"10.3389\/fphar.2021.728315","volume":"12","author":"Liao W.","year":"2022","unstructured":"Liao W.; Xu J.; Li B.; Ruan Y.; Li T.; Liu J.; Deciphering the roles of metformin in Alzheimer\u2019s disease: A snapshot. Front Pharmacol 2022,12,728315","journal-title":"Front Pharmacol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"754123","DOI":"10.3389\/fnagi.2021.754123","volume":"13","author":"Kim J.","year":"2021","unstructured":"Kim J.; Park J.H.; Shah K.; Mitchell S.J.; Cho K.; Hoe H.S.; The anti-diabetic drug gliquidone modulates lipopolysaccharide-mediated microglial neuroinflammatory responses by inhibiting the NLRP3 inflammasome. Front Aging Neurosci 2021,13,754123","journal-title":"Front Aging Neurosci"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/dom.14573","volume":"24","author":"Zullo A.R.","year":"2022","unstructured":"Zullo A.R.; Duprey M.S.; Smith R.J.; Effects of dipeptidyl peptidase\u20104 inhibitors and sulphonylureas on cognitive and physical function in nursing home residents. Diabetes Obes Metab 2022,24(2),247-256","journal-title":"Diabetes Obes Metab"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","volume":"20","author":"Heneka M.T.","year":"2000","unstructured":"Heneka M.T.; Klockgether T.; Feinstein D.L.; Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci 2000,20(18),6862-6867","journal-title":"J Neurosci"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","volume":"106","author":"De Felice F.G.","year":"2009","unstructured":"De Felice F.G.; Vieira M.N.N.; Bomfim T.R.; Protection of synapses against Alzheimer\u2019s-linked toxins: Insulin signaling prevents the pathogenic binding of A\u03b2 oligomers. Proc Natl Acad Sci USA 2009,106(6),1971-1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.lfs.2006.07.018","volume":"79","author":"Pathan A.R.","year":"2006","unstructured":"Pathan A.R.; Viswanad B.; Sonkusare S.K.; Ramarao P.; Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci 2006,79(23),2209-2216","journal-title":"Life Sci"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1176\/appi.ajgp.13.11.950","volume":"13","author":"Watson G.S.","year":"2005","unstructured":"Watson G.S.; Cholerton B.A.; Reger M.A.; Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005,13(11),950-958","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","volume":"6","author":"Risner M.E.","year":"2006","unstructured":"Risner M.E.; Saunders A.M.; Altman J F B.; Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease. Pharmacogenomics J 2006,6(4),246-254","journal-title":"Pharmacogenomics J"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3233\/JAD-2010-100939","volume":"22","author":"Tzimopoulou S.","year":"2011","unstructured":"Tzimopoulou S.; Cunningham V.J.; Nichols T.E.; A multi-center randomized proof-of-concept clinical trial applying [\u00b9\u2078F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer\u2019s disease. J Alzheimers Dis 2011,22(4),1241-1256","journal-title":"J Alzheimers Dis"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","volume":"60","author":"Imfeld P.","year":"2012","unstructured":"Imfeld P.; Bodmer M.; Jick S.S.; Meier C.R.; Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019s disease: a population-based case-control study. J Am Geriatr Soc 2012,60(5),916-921","journal-title":"J Am Geriatr Soc"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/B978-0-12-381517-0.00013-8","volume":"84","author":"H\u00f6lscher C.","year":"2010","unstructured":"H\u00f6lscher C.; The role of GLP-1 in neuronal activity and neurodegeneration. Vitam Horm 2010,84,331-354","journal-title":"Vitam Horm"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"Bomfim T.R.","year":"2012","unstructured":"Bomfim T.R.; Forny-Germano L.; Sathler L.B.; An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease\u2013associated A\u03b2 oligomers. J Clin Invest 2012,122(4),1339-1353","journal-title":"J Clin Invest"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2202-13-33","volume":"13","author":"Hunter K.","year":"2012","unstructured":"Hunter K.; H\u00f6lscher C.; Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 2012,13(1),33","journal-title":"BMC Neurosci"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","volume":"31","author":"McClean P.L.","year":"2011","unstructured":"McClean P.L.; Parthsarathy V.; Faivre E.; H\u00f6lscher C.; The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u2019s disease. J Neurosci 2011,31(17),6587-6594","journal-title":"J Neurosci"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/JAD-130491","volume":"37","author":"Yang Y.","year":"2013","unstructured":"Yang Y.; Zhang J.; Ma D.; Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes. J Alzheimers Dis 2013,37(3),637-648","journal-title":"J Alzheimers Dis"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230102141154","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212333\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230102141154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T12:41:51Z","timestamp":1694176911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212333\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":199,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399819666230102141154","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e020123212333"}}